Signaling Pathways - Calmodulins - cAMP - NOS - Insulin and Insulin-like Receptors
清除全部
- B6345 L-NIO dihydrochlorideTarget: NOSSummary: 一氧化氮(NO)合酶抑制剂
- B6326 Diphenyleneiodonium chloride中文名: 二苯基氯化碘盐Target: NADPH Oxidases|NOS|GPR3Summary: iNOS和eNOS抑制剂,GPR3激动剂
- B6369 7-Nitroindazole中文名: 硝基吲唑Target: NOSSummary: nNOS抑制剂
- B6278 W-7 hydrochlorideTarget: CalmodulinsSummary: 钙调蛋白拮抗剂
- B2194 Tolbutamide中文名: 甲苯磺丁脲Target: cAMP|Sulfonylurea receptorsSummary: 第一代钾通道阻滞剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂
- A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂,有效的胰岛素敏化剂